Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) Gross Profit (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Gross Profit for 2 consecutive years, with $11.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Gross Profit rose 95.97% to $11.4 million in Q4 2025 year-over-year; TTM through Oct 2025 was $34.5 million, a 179.97% increase, with the full-year FY2025 number at $24.2 million, up 6587.85% from a year prior.
  • Gross Profit was $11.4 million for Q4 2025 at Kestra Medical Technologies, up from $8.9 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $11.4 million in Q4 2025 to a low of $880000.0 in Q1 2024.